Symbol
| PCDH7
| contributors: mct - updated : 21-04-2020
|
HGNC name
| protocadherin 7
|
HGNC id
| 8659
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --low
|  
|
by hypermethylation in Androgen-independent prostate cancer (AIPC) | tumoral
|  
|  
| --over
|  
|
in a large number of patients with Castrate resistant prostate cancer (CRPC) | tumoral
|  
|  
| --over
|  
|
frequently in Non-small cell lung cancer (NSCLC) where this event is associated with poor clinical outcome | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| can serve as a novel biomarker for diagnostic and prognosis in patients with gastric cancer | |
low PCDH7 expression is a potential prognostic biomarker for primary non-muscle invasive bladder cancer (NMIBC) | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | prostate | |
PCDH7 may be an attractive target in subsets of patients with Castrate resistant prostate cancer (CRPC) |
| | |